Skip to main content

Advertisement

SpringerLink
Log in

Pentoxifylline in Patients with Oral Submucous Fibrosis—A Randomized Clinical Trial

  • Comparative Study
  • Published:
Journal of Maxillofacial and Oral Surgery Aims and scope Submit manuscript

Abstract

Background and Aim

As far as research regarding any disease is concerned, each and every aspect poses a challenge. One such entity that poses a challenge in our arena is oral submucous fibrosis (OSF) as no effective treatment is available for this progressively disabling condition with high malignant potential. Hence the present study was undertaken with the aim to determine the use of pentoxifylline (PTX) on the clinical and histopathologic course of OSF.

Method

Thirty clinically confirmed OSF patients were categorized randomly into group I and group II. In group I, drug PTX was administered as an adjunct along with other conventional therapies. Group II patients were advised conventional therapies only. Pre- and post-treatment biopsies were obtained for the following parameters:

  1. 1.

    Micro-vascular density (MVD),

  2. 2.

    Area percentage of blood vessels,

  3. 3.

    Severity of fibrosis, and

  4. 4.

    Inflammatory components.

Results

 

  1. 1.

    On comparing MVD in groups I and II there was no significant difference in pre- and post-treatment.

  2. 2.

    On comparing the average area percentage occupied by blood vessels, significant difference was seen in pre- and post-treatment biopsies in group I.

  3. 3.

    On assessment of mouth opening and tongue protrusion, there was no significant improvement in either of the groups individually or in comparison. But when burning sensation of mucosa was assessed, pre- and post-treatment, both groups showed quite significant improvement individually.

Conclusion

Use of pentoxifylline seemed to be questionable, and taking into consideration the long administration time, its use is not recommended for the treatment of OSF patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Mehrotra R, Singh HP, Gupta SC, Singh M, Jain S (2011) Pentoxifylline therapy in the management of oral submucous fibrosis. Asian Pac J Cancer Prev 12:971–974

    PubMed  Google Scholar 

  2. Mehta AK, Panwar SS, Verma RK, Pal AK (2003) Buccal fat pad reconstruction in oral submucosal fibrosis. Med J Armed Forces India 59:340–341

    Article  Google Scholar 

  3. Agrawal D, Gupta S, Agarwal D, Gupta OP, Agarwal M (2010) Role of GSTM1 and GSTT1 polymorphism: susceptibility to oral submucous fibrosis in the north Indian population. Oncology 79:3–4

    Article  Google Scholar 

  4. Nair U, Bartsch H, Nair J (2004) Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms. Mutagenesis 19(4):251–262

    Article  CAS  PubMed  Google Scholar 

  5. Reddy V, Wanjari PV, Banda NR, Reddy P (2011) Oral submucous fibrosis: correlation of clinical grading to various habit factors. Int J Dent Clin 3(1):21–24

    Article  Google Scholar 

  6. Gupta PG, Ray CS (2004) Epidemiology of betel quid usage. Ann Acad Med Singapore 33:315–365

    Google Scholar 

  7. Nataraj S, Guruprasad Y, Shetty JN (2011) A comparative clinical evaluation of buccal fat pad and collagen in surgical management of oral submucous fibrosis. Arch Dent Sci 2(4):17–24

    Google Scholar 

  8. Rajendran R, Rani V, Shaikh S (2006) Pentoxifylline therapy. A new adjunct in the treatment of oral submucous fibrosis. Indian. J Dent Res 17(4):190–198

    CAS  Google Scholar 

  9. Mahajan AD, Tatu RJ, Shenoy NA, Sharma VS (2010) Surgical management of oral submucous fibrosis in an edentulous patient: a procedural challenge. Natl J Maxillofac Surg 1(2):161–163

    Article  PubMed Central  PubMed  Google Scholar 

  10. Khanna JN, Andrade NN (1995) Oral submucous fibrosis—a new concept in surgical management. Int J Oral Maxillofac Surg 24:433–439

    Article  CAS  PubMed  Google Scholar 

  11. Maher R, Aga P, Johnson NW, Sankaranarayanan R, Warnakulasuriya S (1997) Evaluation of multiple micronutrient supplementation in the management of oral submucous fibrosis in Karachi, Pakistan. Nutr Cancer 27(1):41–47

    Article  CAS  PubMed  Google Scholar 

  12. Taneja L, Nagpal A, Vohra P, Anja V (2011) Oral submucous fibrosis: an oral physician approach. J Innovative Dentistry 1(3):78–81

    Google Scholar 

  13. Magnusson M, Gunnarsson M, Berntorp E, Bjorkman S, Hoglund P (2008) Effects of pentoxifylline and its metabolites on platelet aggregation in whole blood from healthy humans. Eur J Pharmacol 581:290–295

    Article  CAS  PubMed  Google Scholar 

  14. Hernandez E, Correa A, Bucio L, Souza V, Kershenobich D, Gutierrez-Ruiz MC (2002) Pentoxifylline diminished acetaldehyde induced collagen production in hepatic stellate cells by decreasing interleukin-6 expression. Pharmacol Res 46:435–443

    Article  CAS  PubMed  Google Scholar 

  15. Zhou Q, Zheng F, Hou F (2009) Inhibition of tubulointerstitial fibrosis by pentoxifylline is associated with improvement of vascular endothelial growth factor expression. Acta Pharmacol Sin 30(1):98–106

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Ward A, Clissold SP (1987) Pentoxifylline: a review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy. Drug Eval 34:50–97

    Article  CAS  Google Scholar 

  17. Streiter RM, Remick DG, Ward PA et al (1988) Cellular and molecular regulation of tumor necrosis factor alpha production by pentoxifylline. Biochem Biophys Res Comm 155:1230–1236

    Article  Google Scholar 

  18. Fahr A, Langer R, Ziegoleit S (1988) Influence of pentoxifylline administered in vivo on the synthesis of prostacyclin in human varicose veins. Biomed Biochem Acta 14:29–34

    Google Scholar 

  19. Matzky R, Darins H, Sehroar K (1982) The release of prostacyclin by pentoxifylline from human vascular tissue. Arzneimittelforschung 32:1315–1318

    CAS  PubMed  Google Scholar 

  20. Fedorowicz Z, Chan Shih-Yen E et al (2008) Interventions for the management of oral submucous fibrosis. Cochrane Database Syst Rev 4: CD007156

  21. Ranganathan K, Mishra G (2006) An overview of classification schemes for OSMF. J Oral Maxillofac Pathol 10:55–58

    Google Scholar 

  22. Chaturvedi VN, Marathe NG (1988) Serum globulins and immunoglobulin in oral submucous fibrosis. Indian Practitioner 41:399–403

    Google Scholar 

  23. Shah N, Sharma PP (1998) Role of chewing and smoking habits in the aetiology of oral submucous fibrosis (OSF): a case control study. J Oral Pathol Med 27:475–479

    Article  CAS  PubMed  Google Scholar 

  24. Pindborg JJ, Mehta FS, Gupta PC, Daftary DK (1968) Prevalence of oral submucous fibrosis among 50,915 Indian villagers. Br J Cancer 22(4):646–654

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Canniff JP, Harvey W, Harris M (1986) Oral submucous fibrosis: its pathogenesis and management. Br Dent J 160(12):429–434

    Article  CAS  PubMed  Google Scholar 

  26. Bhonsle RB, Murti PR, Pindborg JJ, Daftary DK, Mehta FS (1981) Focal vascular dilatations and petechiae in oral submucous fibrosis. Scand J Dent Res 89:270–274

    CAS  PubMed  Google Scholar 

  27. Phatak AG (1978) Serum proteins and immunoglobulins in oral submucous fibrosis. Indian J Otolaryngol 30(1):1–4

    CAS  Google Scholar 

  28. Gupta DS et al (1985) Estimation of major immunoglobulin profile in oral submucous fibrosis by radial immune-diffusion. Int J Oral surg 14:533–537

    Article  CAS  PubMed  Google Scholar 

  29. Shear M, Lemmar J, Dockrat I (1967) Oral submucous fibrosis in South African Indians—An epidemiological study. S Afr J Med Sci 32:41–46

    CAS  PubMed  Google Scholar 

  30. Van Wyk CW et al (1990) Collagen in submucous fibrosis: an electron-microscope study. J Oral Pathol Med 19:182–187

    Article  PubMed  Google Scholar 

  31. Samlaska CP, Winfield EA (1994) Pentoxyfylline. J Am Acad Derm 30(4):603–621

    Article  CAS  PubMed  Google Scholar 

  32. Sclar DA, Tartaglione TA, Fine MJ (1994) Overview of issues related to medical compliance with implications for the outpatient management. Infect Agents Dis 3:266–269

    CAS  PubMed  Google Scholar 

  33. Raz R, Elchanan G, Colodner R et al (1995) Antibiotics twice daily vs four times daily in treatment of streptococcal pharynigitis. Clinical Infect Dis Pract 4:50–54

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oral and Maxillofacial Surgery, K.L.E.V.K Institute of Dental Sciences, Belgaum, 590010, Karnataka, India

    Namdeo Prabhu, Sanjay S. Rao, S. M. Kotrashetti & Shridhar D. Baliga

  2. Department of Oral Medicine and Radiology, Saraswati Medical and Dental College, Lucknow, 227105, Uttar Pradesh, India

    Rakhi Issrani

  3. Department of Oral and Maxillofacial Pathology and Microbiology, K.L.E.V.K Institute of Dental Sciences, Belgaum, 590010, Karnataka, India

    Seema R. Hallikerimath & Punnya V. Angadi

Authors
  1. Namdeo Prabhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sanjay S. Rao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. M. Kotrashetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shridhar D. Baliga
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Seema R. Hallikerimath
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Punnya V. Angadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Rakhi Issrani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rakhi Issrani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prabhu, N., Rao, S.S., Kotrashetti, S.M. et al. Pentoxifylline in Patients with Oral Submucous Fibrosis—A Randomized Clinical Trial. J. Maxillofac. Oral Surg. 14, 81–89 (2015). https://doi.org/10.1007/s12663-013-0580-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12663-013-0580-x

Keywords

Search

Navigation